Renaissance Capital logo

Apria Priced, Nasdaq: APR

Provides home healthcare equipment and services in the US.

Industry: Health Care

Latest Trade: $37.50 0.00 (0.0%)

First Day Return: +16.8%

Return from IPO: +87.5%

Industry: Health Care

We are a leading provider of integrated home healthcare equipment and related services in the United States. We offer a comprehensive range of products and services for in-home care and delivery across three core service lines: (1) home respiratory therapy (including home oxygen and non-invasive ventilation (“NIV”) services); (2) obstructive sleep apnea (“OSA”) treatment (including continuous positive airway pressure (“CPAP”) and bi-level positive airway pressure devices, and patient support services); and (3) negative pressure wound therapy (“NPWT”). Additionally, we supply a wide range of home medical equipment and other products and services to help improve the quality of life for patients with home care needs. Our revenues are generated through fee-for-service and capitation arrangements with Payors for equipment, supplies, services and other items we rent or sell to patients. Through our offerings, we also provide patients with a variety of clinical and administrative support services and related products and supplies, most of which are prescribed by a physician as part of a care plan. We are focused on being the industry’s highest-quality provider of home healthcare equipment and related services, while maintaining our commitment to being a low-cost operator.
more less
IPO Data
IPO File Date 01/15/2021
Offer Price $20.00
Price Range $19.00 - $21.00
Offer Shares (mm) 7.5
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/10/2021
Offer Price $20.00
Price Range $19.00 - $21.00
Offer Shares (mm) 7.5
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Citi
Goldman Sachs
more
Company Data
Headquarters Indianapolis, IN, United States
Founded 1924
Employees 6,350
Website www.apria.com

Apria (APR) Performance